Literature DB >> 22106241

An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.

Jason P Hunt1, Luke O Buchmann, Libo Wang, Dev Abraham.   

Abstract

OBJECTIVE: To analyze the possible correlation between the location of the primary tumor within the thyroid gland and the patterns of central vs lateral compartment lymph node metastasis.
DESIGN: Retrospective analysis of papillary thyroid carcinoma (PTC) treated in an academic university setting from July 1, 2004, through August 31, 2010.
SETTING: Head and neck oncology clinic. PATIENTS: Those receiving surgical therapy for PTC at the University of Utah. MAIN OUTCOME MEASURES: Tumor characteristics of patients with central vs lateral nodal metastatic disease in PTC.
RESULTS: Two hundred one patients with PTC met inclusion criteria. There were 136 females (67.7%), and the mean age was 44.8 years. Histologic subtypes included 68 follicular variants of PTC, 111 conventional variants of PTC, and 22 patients with both follicular and conventional PTC variants. Metastatic nodal disease was confirmed histologically in 81 patients (40.3%): 42 with central nodal disease only (20.9%), 10 with lateral disease only (5.0%), and 29 with both central and lateral nodal disease (14.4%). Positive lateral compartment nodal metastasis correlated with distant metastases (P < .01), extrathyroid extension (P < .05), histologic subtype (conventional PTC greater than follicular variant PTC) (P < .05), and tumor location within the thyroid lobe (P < .01). Tumors involving the superior aspect of the thyroid lobe were more likely to be associated with metastasis to the lateral cervical lymph nodes (P < .01), and 76.9% of patients with lateral cervical lymph node disease had involvement of the superior aspect of the lobe. Thyroid microcarcinomas were not associated with lateral cervical compartments in this study.
CONCLUSIONS: The intrathyroidal location of PTC predicts the pattern of nodal spread. Therefore, patients with PTC involving the superior aspect of the lobe should undergo specific imaging evaluation of the lateral neck compartments to determine the need for lateral compartment neck dissection.

Entities:  

Mesh:

Year:  2011        PMID: 22106241     DOI: 10.1001/archoto.2011.174

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  17 in total

1.  Prophylactic level II neck dissection guided by frozen section for clinically node-negative papillary thyroid carcinoma: is it useful?

Authors:  Dana M Hartl; Abir Al Ghuzlan; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

2.  Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma.

Authors:  Vincent Patron; Martin Hitier; Cécile Bedfert; Alexandre Métreau; Audrey Dugué; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-13       Impact factor: 2.503

3.  Posterosuperior lesion has a high risk of lateral and central nodal metastasis in solitary papillary thyroid cancer.

Authors:  Dong Jin Lee; Kyu Ho Lee; Jin Hwan Kim; Kee Hwan Kwon; Dae Young Yoon; Young Soo Rho
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  Predictive factors for lymph node metastasis in solitary papillary thyroid carcinomas: a retrospective study.

Authors:  Fábio Muradás Girardi; Marinez Bizarro Barra; Cláudio Galleano Zettler
Journal:  Pathol Oncol Res       Date:  2014-05-02       Impact factor: 3.201

5.  An Update on the Risk of Lymph Node Metastasis for the Follicular Variant of Papillary Thyroid Carcinoma with the New Diagnostic Paradigm.

Authors:  Aleksandra M Sowder; Benjamin L Witt; Jason P Hunt
Journal:  Head Neck Pathol       Date:  2017-06-24

6.  Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.

Authors:  Fausto Fama; Marco Cicciù; Giuseppe Lo Giudice; Alessandro Sindoni; Jessica Palella; Arnaud Piquard; Olivier Saint-Marc; Salvatore Benvenga; Ennio Bramanti; Gabriele Cervino; Maria Gioffre Florio
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Interleukin-22 promotes papillary thyroid cancer cell migration and invasion through microRNA-595/Sox17 axis.

Authors:  Zhidan Mei; Li Zhou; Youhua Zhu; Kejia Jie; Daqing Fan; Jian Chen; Xiguo Liu; Liang Jiang; Qike Jia; Wei Li
Journal:  Tumour Biol       Date:  2016-03-29

8.  Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.

Authors:  Jia-Wei Feng; An-Cheng Qin; Jing Ye; Hua Pan; Yong Jiang; Zhen Qu
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

9.  The association between tumor's location and cervical lymph nodes metastasis in papillary thyroid cancer.

Authors:  Ting-Ting Zhang; Xiu-Zhu Qi; Jian-Ping Chen; Rong-Liang Shi; Shi-Shuai Wen; Yu-Long Wang; Qing-Hai Ji; Qiang Shen; Yong-Xue Zhu; Ning Qu
Journal:  Gland Surg       Date:  2019-10

10.  Development and validation of web-based nomograms for predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Yi Dou; Yingji Chen; Daixing Hu; Wei Xiong; Qi Xiao; Xinliang Su
Journal:  Gland Surg       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.